Anticancer Drug DevelopmentEdited by
- Bruce Baguley, The University of Auckland, New Zealand
- David Kerr, University of Oxford, United Kingdom
Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided.
Oncologists, cancer researchers, pharmacologists, molecular biologists, and cell biologists.
Hardbound, 397 Pages
Published: November 2001
Imprint: Academic Press
"..this is a really extensive and comprehensive book on the drug development process. ...There is very little overlap between chapters and all are written by experts in the field. Hundreds of useful references are included for those wanting to go further. ...Very good value...and essential reading for both the scientist and Ph.D. student. Definately one for the library to stock."
Paul Loadman, University of Bradford, UK for BRITISH JOURNAL OF CANCER (2002)
"Well-referenced and indexed...this text would be a useful addition to the clinic, research laboratory and institution library."
P. Parsons, Queensland Institute of Medical Research for CANCER FORUM (2002)